๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Drug interactions in clinical perspective

โœ Scribed by J. Koch-Weser; D. J. Greenblatt

Publisher
Springer
Year
1977
Tongue
English
Weight
379 KB
Volume
11
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Informed consent in clinical research wi
Informed consent in clinical research with drugs in Spain: Perspective of clinical trials committee members
โœ R. Dal-Rรฉ ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer ๐ŸŒ English โš– 667 KB

A survey among members of 16 Clinical Trials Committees and the Clinical Trials Evaluation Team of the Spanish Ministry of Health was carried out to discover their opinions about the procedure used to obtain informed consent in clinical research with drugs. The responses of the 111 persons surveyed

Psychotropic drug metabolism in the canc
Psychotropic drug metabolism in the cancer patient: clinical aspects of management of potential drug interactions
โœ Glenn R. Kalash ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB ๐Ÿ‘ 2 views

An overview of drug metabolism, with particular focus on the cytochrome p450 system, is provided in this review. To date, there has been a growing body of literature concerning the cytochrome p450 enzyme, drug -drug interactions and the role of psychotropic medications when co-administered with medi

Clinical implications of dose-dependent
Clinical implications of dose-dependent cytochrome P-450 drugโ€“drug interactions with antidepressants
โœ C. L. DeVane ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB

The magnitude of drugยฑdrug interactions in vitro involving competitive inhibition of cytochrome (CYP) isozymes by newer antidepressants can theoretically be shown to be dependent upon several factors. These include the concentration of both the substrate and inhibitor, the anity of the inhibitor for